CTIC CTI BioPharma Corp

CTI BioPharma Corp is a biopharmaceutical company. It is focused on the acquisition, development and commercialization of novel targeted therapies.

$5.61  -0.03 (-0.53%)
As of 09/27/2022 10:07:05 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/12/2001
Outstanding shares:  114,385,307
Average volume:  3,906,483
Market cap:   $665,722,487
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BD8ZGH6
Valuation   (See tab for details)
PE ratio:   -17.91
PB ratio:   153.16
PS ratio:   290.08
Return on equity:   422.03%
Net income %:   -5,133.64%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy